Remote Patient Monitoring Landscape
Where RPM unit economics actually work.
A defensible view of the RPM landscape — by chronic condition, device, payer model and clinical evidence.
"Which RPM models scale durably — and which face economic gravity?"
Hypertension, diabetes and CHF RPM scale on Medicare reimbursement. Other conditions need outcome-based contracting to scale.
RPM economics depend almost entirely on payer model. CMS-aligned chronic care management scales; outcome-based plays scale slower but more durably.
What we’re seeing in the data.
CMS reimbursement is the engine
CPT codes 99453–99458 power scale.
Adherence drives outcomes
And outcomes drive payer renewal.
Pharma RPM tie-ins emerging
Adherence + RWE for pharma launches.
How to think about it.
-
01
Pick condition
Reimbursement-aligned.
-
02
Choose device
Cellular > BYOD typically.
-
03
Build clinical model
Nurse, MD, hybrid.
-
04
Track outcomes
Adherence + clinical KPIs.
What separates a good answer from a defensible one.
Subsidy + retention.
Older patients.
EHR pipelines.
Where the signal comes from.
Common questions.
Best RPM business model?
CMS-aligned chronic care management with strong clinical model.
Outcome-based contracting?
Required for non-CMS-reimbursed conditions.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist